Evidence map›Paper›PMID 33574943›Full record

ArticleOncology letters2021

Gene expression profiling of CD34(+) cells from patients with myeloproliferative neoplasms.

Mugdha Sharma, Chandra Bhavani, Srinag Bangalore Suresh, John Paul, Lokendra Yadav, Cecil Ross, Sweta Srivastava

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mugdha SharmaDepartment of Medicine, St. John's Medical College and Hospital, Bengaluru, Karnataka 560034, India.
Chandra BhavaniSt. John's Research Institute, St. John's National Academy of Health Sciences, Bengaluru, Karnataka 560034, India.
Srinag Bangalore SureshDepartment of Medicine, St. John's Medical College and Hospital, Bengaluru, Karnataka 560034, India.
John PaulDepartment of Medicine, St. John's Medical College and Hospital, Bengaluru, Karnataka 560034, India.
Lokendra YadavDepartment of Transfusion Medicine and Immunohematology, St. John's Medical College and Hospital, Bengaluru, Karnataka 560034, India.
Cecil RossDepartment of Medicine, St. John's Medical College and Hospital, Bengaluru, Karnataka 560034, India.
Sweta SrivastavaDepartment of Transfusion Medicine and Immunohematology, St. John's Medical College and Hospital, Bengaluru, Karnataka 560034, India.
St.John's Medical College Hospital · INSt. John's National Academy of Health Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myeloproliferative neoplasms (MPN) are clonal disorders characterized by the increased proliferation of hematopoietic stem cell precursors and mature blood cells. Mutations of Janus kinase 2 (

Indexed as

CD34cell cyclechromatinepigeneticsJAKmicroarrayMYBmyeloproliferative neoplasm

Identifiers

PMID33574943
PMCPMC7816297
OpenAlexW3118611105

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.